MicroRNA-Regulated Gene Delivery Systems for Research and Therapeutic Purposes

被引:25
作者
Dhungel, Bijay [1 ,2 ,3 ]
Ramlogan-Steel, Charmaine A. [2 ,4 ]
Steel, Jason C. [2 ,5 ]
机构
[1] Greenslopes Private Hosp, Gallipoli Med Res Inst, 102 Newdegate St, Brisbane, Qld 4120, Australia
[2] Univ Queensland, Fac Med, 288 Herston Rd, Brisbane, Qld 4006, Australia
[3] Univ Queensland, Diamantina Inst, Translat Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia
[4] Layton Vis Fdn, Translat Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia
[5] OcuGene, Translat Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia
关键词
gene delivery; gene therapy; targeted transgene expression; microRNA; post-transcriptional targeting; ADENOASSOCIATED VIRAL VECTORS; TRANSGENE EXPRESSION; IN-VIVO; HEPATOCELLULAR-CARCINOMA; ENDOGENOUS MICRORNA; ONCOLYTIC ADENOVIRUSES; BINDING SITES; SMALL RNAS; VIRUS; TISSUE;
D O I
10.3390/molecules23071500
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Targeted gene delivery relies on the ability to limit the expression of a transgene within a defined cell/tissue population. MicroRNAs represent a class of highly powerful and effective regulators of gene expression that act by binding to a specific sequence present in the corresponding messenger RNA. Involved in almost every aspect of cellular function, many miRNAs have been discovered with expression patterns specific to developmental stage, lineage, cell-type, or disease stage. Exploiting the binding sites of these miRNAs allows for construction of targeted gene delivery platforms with a diverse range of applications. Here, we summarize studies that have utilized miRNA-regulated systems to achieve targeted gene delivery for both research and therapeutic purposes. Additionally, we identify criteria that are important for the effectiveness of a particular miRNA for such applications and we also discuss factors that have to be taken into consideration when designing miRNA-regulated expression cassettes.
引用
收藏
页数:14
相关论文
共 110 条
[1]   A Double-Switch Vector System Positively Regulates Transgene Expression by Endogenous microRNA Expression (miR-ON Vector) [J].
Amendola, Mario ;
Giustacchini, Alice ;
Gentner, Bernhard ;
Naldini, Luigi .
MOLECULAR THERAPY, 2013, 21 (05) :934-946
[2]   Molecular basis for target RNA recognition and cleavage by human RISC [J].
Ameres, Stefan Ludwig ;
Martinez, Javier ;
Schroeder, Renee .
CELL, 2007, 130 (01) :101-112
[3]   In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance [J].
Annoni, Andrea ;
Brown, Brian D. ;
Cantore, Alessio ;
Sergi, Lucia Sergi ;
Naldini, Luigi ;
Roncarolo, Maria-Grazia .
BLOOD, 2009, 114 (25) :5152-5161
[4]   Target mRNA abundance dilutes microRNA and siRNA activity [J].
Arvey, Aaron ;
Larsson, Erik ;
Sander, Chris ;
Leslie, Christina S. ;
Marks, Debora S. .
MOLECULAR SYSTEMS BIOLOGY, 2010, 6
[5]   MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus [J].
Baertsch, M. A. ;
Leber, M. F. ;
Bossow, S. ;
Singh, M. ;
Engeland, C. E. ;
Albert, J. ;
Grossardt, C. ;
Jaeger, D. ;
von Kalle, C. ;
Ungerechts, G. .
CANCER GENE THERAPY, 2014, 21 (09) :373-380
[6]   Managing MicroRNAs with Vector-Encoded Decoy-Type Inhibitors [J].
Bak, Rasmus O. ;
Hollensen, Anne Kruse ;
Mikkelsen, Jacob Giehm .
MOLECULAR THERAPY, 2013, 21 (08) :1478-1485
[7]   Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines [J].
Barnes, Dwight ;
Kunitomi, Mark ;
Vignuzzi, Marco ;
Saksela, Kalle ;
Andino, Raul .
CELL HOST & MICROBE, 2008, 4 (03) :239-248
[8]   Metazoan MicroRNAs [J].
Bartel, David P. .
CELL, 2018, 173 (01) :20-51
[9]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[10]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29